Molecular pathways in dermatotoxicology

Toxicology and Applied Pharmacology

Volumn 195, Issue 3, 2004, Pages 267-277

  Merk, H F ^b   Abel, J ^b   Baron, J M ^b   Krutmann, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

Dermatotoxicology; Environment; Skin cells

Indexed keywords

CARBAMAZEPINE; CARRIER PROTEIN; CERAMIDE; CYTOCHROME C; FRAGRANCE; HAPTEN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE LIPID; PHENYLENEDIAMINE; SPHINGOMYELIN; TRANSCRIPTION FACTOR AP 2; XENOBIOTIC AGENT;

CANCER RISK; CHEMICAL CARCINOGENESIS; DNA DAMAGE; DRUG HYPERSENSITIVITY; HUMAN; INFRARED RADIATION; MITOCHONDRION; MOLECULAR BIOLOGY; NONHUMAN; RADIATION EXPOSURE; RADIATION RESPONSE; REVIEW; SIGNAL TRANSDUCTION; SKIN ALLERGY; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN CELL; SKIN TOXICITY; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; XENOBIOTIC METABOLISM;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; DERMATITIS, ALLERGIC CONTACT; HUMANS; INFRARED RAYS; SKIN; SKIN ABSORPTION; SKIN NEOPLASMS; ULTRAVIOLET RAYS; XENOBIOTICS;

EID: 1542512398     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.09.023     Document Type: Review

References (82)

1. Balmain A., Brown K., Akhurst R.J., Fee F.M. Molecular analysis of chemical carcinogenesis in the skin. Br. J. Cancer Suppl. 9:1988;72-75.
2. Baron J.M., Goh L.B., Denggao Y., Wolf C.R., Friedberg T. Modulation of P450 CYP3A4 dependent metabolism by p-glycoprotein: implications for P450 phenotyping. J. Pharmacol. Exp. Ther. 296:2001;351-358.
3. Baron J.M., Höller D., Schiffer R., Frankenberg S., Neis M., Merk H.F., Jugert F. Expression of multiple cytochrome P450 enzymes and MDR-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol. 116(4):2001;541-548.
4. Baron J.M., Neis M., Höller D., Schiffer R., Zwadlo-Klarwasser G., Merk H.F., Jugert F. Transporter proteins and xenobiotica metabolizing enzymes in skin cells. Ring J., Weidinger S., Darsow U., Editore M. Skin and Environment - Perception and Protection. Proceedings Division of 10th European Academy of Dermatology and Venerology. 2002;455-461.
5. Basketter D.A. Skin sensitization to cinnamic alcohol: the role of skin metabolism. Acta. Derm.-Venereol. 72:1992;264-265.
6. Bender K., Blatter C., Knebel A., Iordanow M., Herrlich P., Rahmsdorf H.J. UV-induced signal transduction. J. Photochem. Photobiol., B Biol. 37:1997;1-17.
7. Berneburg M., Krutmann J. Photoimmunology, DNA repair and photocarcinogenesis. Invited review. J. Photochem. Photobiol., B Biol. 54:2000;87-93.
8. Betrand F., Basketter D.A., Roberts D.W., Lepoittevin J.P. Skin sensitization to eugenol and isoeugenol in mice: possible metabolic pathways involving ortho-quinone and quinone methide intermediates. Chem. Res. Toxicol. 10:1997;335-343.
9. Borst P., Kool M., Evers R. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR. Cancer Biol. 8:1997;205-213.
10. Brash D., Ponten J. Skin precancer. Cancer Surv. 32:1998;69-113.
11. Bürger F., Krieg P., Kinzig A., Schurich B., Marks F., Fürstenberger G. Constitutive expression of 8-lipoxygenase in papillomas and clastogenic effects of lipoxygenase-derived arachidonic acid metabolites. Mol. Carcinog. 24:1999;108-117.
12. Conney A.H. Induction of drug metabolizing enzymes: a path to the discovery of multiple cytochromes P450. Annu. Rev. Pharmacol. Toxicol. 43:2003;1-30.
13. De Groot A.C., Frosch P.J. Adverse reactions to fragrances. Contact Dermatitis. 36:1997;57-86.
14. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54:1992;63-128.
15. Ding X., Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotica metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43:2003;149-173.
16. Donehower L.A., Harvey M., Slage B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
17. Drinkwater N.R. Experimental models and biological mechanisms for tumor promotion. Cancer Cells. 2:1990;8-15.
18. Fernandez-Salguero P.M., Ward J.M., Sundberg J.P., Gonzalez F.J. Lesions of aryl-hydrocarbon receptor-deficient mice. Vet. Pathol. 34:1997;605-614.
19. Fischer S.M. Is cyclooxygenase-2 important in skin carcinogenesis? J. Environ. Pathol. Toxicol. Oncol. 21:2002;183-191.
20. Flens M.J., Zaman J.R., van der Valk P., Izquierdi M.A., Schroeijers A.B., Scheffer G.L., van der Groep P., de Haas M., Meijer C.J., Scheper R.J. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1996;1237-1247.
21. Fürstenberger G., Gross M., Marks F. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis. 10:1989;91-96.
22. Greenblatt M.S., Benett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor genes: clues to etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
23. Greenhalgh D.A., Rothnagel J.A., Quintilla M.I., Orengo C.C., Gagne T.A., Bundman D.S., Longley M.A., Roop D.R. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice targeted v-Ha-ras oncogene. Mol. Carcinog. 7:1993;99-110.
24. Greenhalgh D.A., Rothnagel J.A., Wang X.J., Quintilla M.I., Orengo C.C., Gagne T.A., Bundman D.S., Longley M.A., Roop D.R. Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia. Oncogene. 8:1993;2145-2157.
25. Greenhalgh D.A., Wang X.J., Donehower L.A., Roop D.R. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice express epidermal-targeted v-rasHA, v-fos, or transforming growth factor alpha. Cancer Res. 56:1996;4413-4423.
26. Grether-Beck S., Olaizola-Horn S., Schmitt H., Grewe M., Jahncke A., Johnson J.P., Briviba K., Sies H., Krutmann J. Activation of transcription factor AP2 mediates ultraviolet A radiation and singlet oxygen induced expression of the human ICAM-1 gene. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14586-14591.
27. Grether-Beck S., Bonnizzi G., Felsner I., Timmer A., Schmitt-Brenden H., Sies H., Johnson J.P., Piette J., Krutmann J. Non-enzymatic triggering of the ceramide signaling cascade by solar ultraviolet A radiation. EMBO J. 19:2000;5793-5800.
28. Grether-Beck S., Buettner R., Krutmann J. Ultraviolet A radiation-induced expression of human genes: molecular and photobiological mechanisms. J. Biol. Chem. 378:2002;1231-1236.
29. Grether-Beck S., Felsner I., Schmitt-Brenden H., Krutmann J. Mitochondrial cytochrome C release mediates ceramide-induced AP-2 activation and gene expression in human keratinocytes. J. Biol. Chem. 28:2003;47498-47507.
30. Guengerich F.P. Metabolic activation of carcinogens. Pharmacol. Ther. 54:1992;17-61.
31. Heidt M., Fürstenberger G., Vogel S., Marks F., Krieg P. Diversity of murine lipoxygenases: identification of a subfamily of epidermal isoenzymes exhibiting a differentiation-dependent mRNA expression pattern. Lipids. 34:2000;701-707.
32. Hertl M., Jugert F., Merk H.F. CD8+ dermal T-cells from a sulfamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br. J. Dermatol. 132:1995;215-220.
33. Hertl M., Niederau D., Merk H. The use of epidermal and dermal T-lymphocyte clones in studies on the pathophysiology of bullous drug eruptions. Maibach H.I. Dermatologic Research Techniques. 1996;11-22 CRC Press, Boca Raton.
34. Hunter J., Jepson M.A., Tsuruo T., Simmons N.L., Hirst B.H. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 Cells. J. Biol. Chem. 268:1993;14991-14997.
35. Jacks T. Lessons from the p53 mutant mouse. J. Cancer Res. Clin. Oncol. 122:1996;319-327.
36. Jugert F., Agarwal R., Kuhn A., Bickers D.R., Merk H.F., Mukhtar H. Multiple cytochrome P450 enzymes in murine skin: induction of P4501A, 2B, 2E, and 3A by dexamethasone. J. Invest. Dermatol. 102:1994;970-975.
37. Karlberg A.T., Bohlinder K., Boman A., Hachsell U., Hermansson J., Jacobsson S., Nilsson J.L.G. Identification of 15-hydroperoxyabietic acid as a contact allergen in Portuguese colophony. J. Pharm. Pharmacol. 40:1988;42-47.
38. Karlberh A.T., Shao L.P., Nilsson U., Gäfvert E., Nilsson J.L.G. Hydroperoxides in oxidized d-limonene identified as potent contact allergens. Arch. Dermatol. Res. 286:1994;97-103.
39. Kawakubo Y., Merk H.F., Masaoudi T.A., Sieben S., Blomeke B. N-acetylation of paraphenylenediamine in human skin and keratinocytes. J. Pharmacol. Exp. Ther. 292(1):2000;150-155.
40. Keeney D.S., Skinner C., Travers J.B., Capdevila J.H., Nanney L.B., King L.E., Waterman M.R. Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J. Biol. Chem. 273(48):1998;32071-32079.
41. Kemp C.J., Donehower L.A., Bradley A., Balmain A. Reduction of p53 dosage does not increase initiation and promotion but enhances malignant progression of chemically induced skin tumors. Cell. 74:1993;813-822.
42. Kleiner H.E., Vulimiri S.V., Reed M.J., Uberecken A., DiGiovanni J. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. Chem. Res. Toxicol. 15:2002;226-235.
43. Kool M., de Haas M., Scheffer G.L., Scheper R.J., van Eijk M.J., Juijn J.A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:1997;3537-3547.
44. Krieg P., Kinzig A., Ress-Löscke M., Vogel S., VanLandingham B., Stephan M., Lehmann W.D., Marks F., Fürstenberger G. 12-Lipoxygenase isoenzymes in mouse skin tumor development. Mol. Cancer. 14:1995;118-129.
45. Krutmann J. New developments in photoprotection of human skin. Skin Pharmacol. Appl. Skin Physiol. 14:2001;401-407.
46. Kühn H., Thiele B.J. The diversity of lipoxygenase family. FEBS. 449:1999;7-11.
47. Kulms D., Pöppelmann B., Yarosh D., Luger T.A., Krutmann J., Schwarz T. Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7974-7979.
48. Lim H.W., Soter N.A. Clinical Photomedicine. 1993;Marcel Dekker, New York.
49. Marks F., Fürstenberger G. Eicosanoids and cancer. Marks F., Fürstenberger G. Prostaglandins, Leukotrienes, and other Eicosanoids. 1999;303-330 Wiley-VHC, Weinheim, Germany.
50. Marks F., Muller-Decker K., Fürstenberger G. A causal relationship between unscheduled eicosanoid signalling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology. 153:2000;11-26.
51. Merk H.F., Jugert F.K. Metabolic activation and detoxification of drugs and xenobiotica by the skin. Gurny R., Teubner A. Dermal and Transdermal Drug Delivery - New Insights and Perspectives. 1993;91-100 Wissenschaftliche Verlagsgesellschaft, Stuttgart.
52. Merk H.F., Schneider R., Scholl P. Lymphocyte stimulation by drug-modified microsomes. Estabrook R.W., Lindenlaub E., Oesch F., de Weck A.L. Toxicological and Immunological Aspects of Drug Metabolism and Environmental Chemicals. 1988;211-219 Schattauer.
53. Mimura J., Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochem. Biophys. Acta. 1619:2003;263-268.
54. Mimura J., Ema M., Sogaw K., Fjii-Kuriyama Y. Identification of a novel mechanism of regulation of a (dioxin) receptor function. Genes Dev. 13:1999;20-25.
55. Müller K., Siebert M., Heidt M., Marks F., Fürstenberger G. Modulation of epidermal tumor development caused by targeted overexpression of epidermis-type 12s-lipoxygenase. Cancer Res. 62:2002;4610-4616.
56. Müller-Decker K., Scholz K., Marks F., Fürstenberger G. Differential expression of prostaglandin H synthase isoenzymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinog. 12:1995;31-41.
57. Nair J., Fürstenberger G., Burger F., Marks F., Bartsch H. Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: correlation with lipoxygenase-catalyzed arachidonic acid metabolism. Chem. Res. Toxicol. 13:2000;703-709.
58. Naisbitt D.J., Gordon S.F., Pirmohamed M., Burkhart C., Cribb A.E., Pichler W.J., Park B.K. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br. J. Pharmacol. 133:2001;295-305.
59. Qunitilla M., Brown K., Ramsden M., Balmain A. Carcinogenic specific mutations and amplifications of Ha-ras during mouse skin carcinogenesis. Nature. 322:1986;78-80.
60. Ringpfeil F., Lebwohl M.G., Christiano A.M., Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. U. S. A. 97(11):2000;6001- 6006.
61. Sachs B., Erdmann S., Al-Masaoudi T., Merk H.F. In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretion. Br. J. Dermatol. Feb. 144(2):2001;316-320.
62. Schieke S., Stege H., Kürten V., Grether-Beck S., Sies H., Krutmann J. Infrared-A radiation-induced matrix metalloproteinase 1 expression is mediated through extracellular signal-regulated kinase 1/2 activation in human dermal fibroblasts. J. Invest. Dermatol. 119:2002;1323-1329.
63. Schieke S., Schroeder P., Krutmann J. Cutaneous effects of infrared radiation: from clinical observations to molecular response mechanisms. Photodermatol. Photoimmunol. Photomed. 18:2003;1-7.
64. Schiffer R., Neis M., Holler D., Rodriguez F., Geier A., Gartung C., Lammert F., Dreuw A., Zwadlo-Klarwasser G., Merk H., Jugert F., Baron J.M. Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. J. Invest. Dermatol. 120(2):2003;285-291.
65. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., Fujii-Kuriyama Y., Takatoshi I. Benzo(a)pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. PNAS. 97:2000;779-782.
66. Schnyder B., Mauri-Hellweg D., Zanni M., Bettens F., Pichler W.J. Direct MHC-dependent presentation of the drug sulfamethoxazole to human αβ T cell clones. J. Clin. Invest. 100:1997;136-141.
67. Sieben S., Hertl M., Al Masaaoudi P., Merk H.F., Blömeke B. Characterization of T cell responses to fragrances. Toxicol. Appl. Pharmacol. 172:2001;172-178.
68. Sieben S., Kawakubo Y., Massoudi T.A., Merk H.F., Blömeke B. Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific αβ+ human T-cell clones. J. Allergy Clin. Immunol. 109:2002;1005-1011.
69. Slaga T.J. Inhibition of skin tumor initiation, promotion, and progression by antioxidants and related compounds. Crit. Rev. Food Sci. Nutr. 35:1995;51-57.
70. Sleeman M.A., Watson J.D., Murison J.G. Neonatal murine epidermal cells express a functional multidrug-resistant pump. J. Invest. Dermatol. 115:2000;19-23.
71. Smith C.K., Moore C.A., Elahi N.E., Smart A.T.S., Hotchkiss A.M. Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. Toxicol. Appl. Pharmacol. 168:2000;189-199.
72. Stege H., Roza L., Vink A.A., Grewe M., Ruzicka T., Grether-Beck S., Krutmann J. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1790-1795.
73. Tamai I., Nezu J., Uchino H., Sai Y., Oku A., Shimane M., Tsuji A. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 273:2000;251-260.
74. Tiano H.F., Charles D., Loftkin J., Akund J., Lee Ch.A., Spalding J., Sessoms A., Dunson D.B., Rogan E.G., Morham S.G., Smart R.C., Langenbach R. Deficiency of either cyclooxygenase (cox)-1 or cox-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 62:2002;3395-3401.
75. Traidl C., Merk H.F., Cavani A., Hunzelmann N. New insights into the pathomechanisms of contact dermatitis by the use of transgenic mouse models. Skin Pharmacol. Appl. Skin Physiol. 13:2000;300-312.
76. Wacher V.J., Wu C.Y., Benet L.Z. Overlapping substrate distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 13:1995;129-134.
77. Wang X.Y., Greenhalg D.A., Jiang A., He A., Zhong L., Medina D., Brinkley B.R., Roop R.D. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Oncogene. 17:1998;35-45.
78. Wolkenstein P., Tan C., Lecoeur S., Wechsler J., Garcia-Martin N., Charue D., Bagot M., Beaune Ph. Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. Chem. Biol. Interact. 113:1998;39-50.
79. Yarosh D., Klein J., O'Connor A., Hawk J., Rafal E., Wolf P. for the Xeroderma pigmentosum Study Group Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomized study. Lancet. 357:2001;926-929.
80. Yuspa S.H. Cutaneous chemical carcinogenesis. J. Am. Acad. Dermatol. 15:1986;1031-1044.
81. Yengi L.G., Xiang Q., Pan J., Scatina J., Kao J., Ball S.E., Fruncillo R., Ferron G., Wolf R. Quantification of cytochrome P450 mRNA levels in human skin. Anal. Biochem. 316:2003;103-110.
82. Zhu Z., Hotchkiss S.A., Boobis A.R., Edwards R.J. Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. BBRC. 297:2002;65-70.